CD2 molecule trigger cancer recognition in natural killer cells
Friday, April 22, 2016 - 13:20
in Health & Medicine
A study reveals a molecule that triggers cancer recognition in natural killer (NK) cells. The study defines an important role for CD2 in stimulating NK cell responses to therapeutic antibodies. The findings pave the way for improving antibody-based cancer immunotherapy and to develop new cell therapy against cancer based on the cytotoxic potential of NK cells.